Relationship between histologic features of primary breast carcinomas and axillary lymph node micrometastases: Detection and prognostic significance

Applied Immunohistochemistry and Molecular Morphology

Volumn 14, Issue 4, 2006, Pages 426-431

  Marinho, Vanessa Fortes Zschaber ^a   Zagury, Marcos Salomão ^a   Caldeira, Lidiane Gomes ^a   Gobbi, Helenice ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Breast cancer; Immunohistochemistry; Lymph node; Micrometastases; Prognosis

Indexed keywords

CYTOKERATIN AE1; CYTOKERATIN AE3; EOSIN; HEMATOXYLIN;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER GRADING; CANCER INVASION; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE FREE SURVIVAL; HISTOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROMETASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS;

EID: 33751430264     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/01.pai.0000210419.45869.79     Document Type: Article

References (31)

1. Fitzgibbons PL, Page DL, Weaver D, et al. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000;124:966-978.
2. Fitzgibbons PL, Connolly JL, Page DL. Updated protocol for the examination of specimens from patients with carcinomas of the breast. Arch Pathol Lab Med. 2000;124:1026-1033.
3. Cote RJ, Peterson HF, Chaiwun B, et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. Lancet. 1999;354:896-900.
4. Mies C, Schlesselman JJ. Detection of "occult" lymph node metastasis in breast cancer: should pathologists go the extra mile? Adv Anat Pathol. 2000;7:149-152.
5. Fisher B, Costantino J, Redmond C, et al. A randomized clinical trial evaluating Tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med. 1989;320:479-484.
6. Fisher B, Dignam J, Mamounas EP, et al. Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer with estrogen-receptor-negative tumors: eight year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first results of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate and fluorouracil. J Clin Oncol. 1996;14:1982-1992.
7. Millis RR, Springall R, Lee AHS, et al. Occult axillary lymph node metastases are of no prognostic significance in breast cancer. Br J Cancer. 2002;86:396-401.
8. Huvos AG, Hutter RVP, Berg JW. Significance of axillary macrometastases and micrometastases in mammary cancer. Ann Surg. 1971;1:44-46.
9. Greene FK, Page DL, Fleming ID, et al. Breast. In: Greene FK, Page DL, Fleming ID, et al, eds. AJCC Cancer Staging Manual. 6th ed. New York: Springer; 2002:223-240.
10. Zhang PJ, Reisner RM, Nangia R, et al. Effectiveness of multiplelevel sectioning in detecting axillary nodal micrometastasis in breast cancer. A retrospective study with immunohistochemical analysis. Arch Pathol Lab Med. 1998;122:687-690.
11. DeMascarel I, Bonichon F, Coindre JM, et al. Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up. Br J Cancer. 1992;66:523-527.
12. Dowlatshahi K, Fan M, Snider HC, et al. Lymph node micrometastases from breast carcinoma. Reviewing the dilemma. Cancer. 1997;80:1188-1197.
13. Hermanek P, Hutter RVP, Sobin LH, et al. Classification of isolated tumor cells and micrometastasis. Cancer. 1999;86:2668-2673.
14. Jain RK, Fenton BT. Intratumoral lymphatic vessels: a case of mistaken identity or malfunction? J Natl Cancer Inst. 2002;94:417-421.
15. Keene SA, Demeure MJ. The clinical significance of micrometastases and molecular metastases. Surgery. 2001;129:1-5.
16. Page DL, Anderson TJ, Carter BA. Minimal solid tumor involvement of regional and distant sites. When is a metastasis not a metastasis? Cancer. 1999;86:2589-2592.
17. Chadha M, Chabon AB, Friedmann P, et al. Predictors of axillary lymph node metastases in patients with T1 breast cancer. A multivariate analysis. Cancer. 1994;73:350-353.
18. Middleton LP, Tressera F, Sobel ME, et al. Infiltrating micropapillary carcinoma of the breast. Mod Pathol. 1999;12:499-504.
19. Page DL, Jensen RA, Simpson JF. Routinely available indicators of prognosis in breast cancer. Breast Cancer Res Treat. 1998;51:195-208.
20. Tavassoli FA, Ellis IO, Schnitt SJ, et al. Invasive Breast Carcinoma. In: Tavassoli FA, Devilee P, eds. Pathology & Genetics Tumours of the Breast and Female Genital Organs. Lyon: IARC Press; 2003:9-112.
21. Elston CW, Ellis IO. Assessment of histological grade. In: Elston CW, Ellis IO, eds. The Breast. Edinburgh: Churchill Livingstone; 1998:365-384.
22. Hartveit F, Lilleng PK. Breast cancer: two micrometastatic variants in the axilla that differ in prognosis. Histopathology. 1996;28:241-246.
23. Lilleng PK, Maehle BO, Hartveit F. The size of a micrometastasis in the axilla in breast cancer: a study of nodal tumor-load related to prognosis. Eur J Gynaec Oncol. 1998;3:220-224.
24. International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet. 1990;335:1565-1568.
25. McGuckin MA, Cummings MC, Walsh MD, et al. Occult axillary node metastases in breast cancer: their detection and prognostic significance. Br J Cancer. 1996;73:88-95.
26. Carter BA, Jensen RA, Simpson JF, et al. Benign Transport of breast epithelium into axillary lymph nodes after biopsy. Am J Clin Pathol. 2000;113:259-265.
27. Weaver DL. Micrometastases in sentinel lymph nodes. Pathological aspects. Pathol Case Rev. 2003;8:220-226.
28. Warr D, Miller N. Micrometastases in sentinel lymph node biopsies: The medical oncologist's perspective: to treat or not to treat? Pathol Case Rev. 2003;8:227-232.
29. Bloom HJG, Richardson WW. Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer. 1957;11:359-367.
30. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19:403-410.
31. Attiyeh FF, Jensen M, Huvos AG, et al. Axillary micrometastasis and macrometastasis in carcinoma of the breast. Surg Gynecol Obstet. 1977;144:839-842.